During the past decade, Fundação Universidade de Caxias do Sul conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundação Universidade de Caxias do Sul" are "Colitis, Ulcerative" (1 trials), "Covid19" (1 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials) and "Relapsed or Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Fundação Universidade de Caxias do Sul" in a lesser frequency.

Most popular intervention types in "Fundação Universidade de Caxias do Sul" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundação Universidade de Caxias do Sul" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Fundação Universidade de Caxias do Sul". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fundação Universidade de Caxias do Sul, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundação Universidade de Caxias do Sul, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".